We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

68 hedge funds and large institutions have $372M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

3% more call options, than puts

Call options by funds: $7.86M | Put options by funds: $7.63M

4% less funds holding

Funds holding: 7168 (-3)

10% less capital invested

Capital invested by funds: $412M → $372M (-$39.3M)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

Holders
68
Holders Change
-3
Holders Change %
-4.23%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
27
Reduced
22
Closed
15
Calls
$7.86M
Puts
$7.63M
Net Calls
+$231K
Net Calls Change
+$866K
Name Holding Trade Value Shares
Change
Change in
Stake
TA
26
Teachers Advisors
New York
$1.09M +$105K +7,640 +10%
Swiss National Bank
27
Swiss National Bank
Switzerland
$711K +$128K +9,300 +21%
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$708K +$19.7K +1,430 +3%
AQR Capital Management
29
AQR Capital Management
Connecticut
$700K -$1.33M -96,789 -64%
State Board of Administration of Florida Retirement System
30
State Board of Administration of Florida Retirement System
Florida
$695K
MLICM
31
Metropolitan Life Insurance Company (MetLife)
New York
$641K +$9.17K +666 +1%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$624K -$35.8K -2,600 -5%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$620K
NFA
34
Nationwide Fund Advisors
Ohio
$601K -$19.2K -1,397 -3%
EAM
35
Eventide Asset Management
Massachusetts
$526K +$556K +40,400 New
BA
36
BlackRock Advisors
Delaware
$518K +$44.9K +3,260 +9%
AIG
37
American International Group
New York
$515K +$33.5K +2,435 +7%
Deutsche Bank
38
Deutsche Bank
Germany
$482K -$723K -52,504 -59%
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$475K +$41.3K +3,000 +10%
Citigroup
40
Citigroup
New York
$429K +$295K +21,436 +186%
ProShare Advisors
41
ProShare Advisors
Maryland
$408K -$376K -27,295 -47%
Morgan Stanley
42
Morgan Stanley
New York
$332K +$46.3K +3,363 +15%
HCM
43
Highbridge Capital Management
New York
$331K +$1.38K +100 +0.4%
UBS AM
44
UBS AM
Illinois
$311K -$8.26K -600 -2%
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$301K +$318K +23,100 New
JP Morgan Chase
46
JP Morgan Chase
New York
$296K -$9.65M -700,994 -97%
CA
47
Commerzbank Aktiengesellschaft
Germany
$247K +$218K +15,857 New
CLOS
48
Compagnie Lombard Odier SCmA
Switzerland
$234K +$248K +18,000 New
Bank of America
49
Bank of America
North Carolina
$226K +$193K +14,002 +415%
EMG
50
Ellington Management Group
Connecticut
$216K +$229K +16,600 New

RPTP Hedge Fund Activity: Q4 2013 in Review

68 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2013, worth a combined $372M — down 9.5% from $412M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of RPTP and 12 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 27 added.

The largest buyer was Goldman Sachs, adding an estimated $39.6M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $14.9M sold.

  • 68 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2013, down from 71 in Q3 2013.
  • Funds reported $372M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2013, down 9.5% quarter-over-quarter.
  • 12 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2013 and 15 closed out, a net change of -3 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q4 2013 was Goldman Sachs, an estimated $39.6M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2013 was Adage Capital Partners, an estimated $14.9M sold.

Based on aggregated 13F filings for Q4 2013.